Tandem Freedom - Feasibility Trial 2
NCT: NCT06834568 · COMPLETED
NCT IDNCT06834568
StatusCOMPLETED
Start Date2025-03-24
Completion2025-04-07
Brief Summary
This feasibility study is a prospective, single arm study evaluating the Tandem Freedom system in adults with type 1 diabetes. Existing Control-IQ technology users will use Control-IQ technology at home for a one week run-in, then will use Tandem Freedom in a supervised hotel setting.
Frequently Asked Questions
What is Tandem Freedom - Feasibility Trial 2?
Tandem Freedom - Feasibility Trial 2 is a clinical trial registered under NCT06834568. Current status: COMPLETED.
What is the status of NCT06834568?
The current status of NCT06834568 (Tandem Freedom - Feasibility Trial 2) is: COMPLETED.
When did Tandem Freedom - Feasibility Trial 2 start?
Tandem Freedom - Feasibility Trial 2 started on 2025-03-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.